Tag Archives: Blackstone Life Sciences

Blackstone Provides $1B in Funding to PTC Therapeutics

PTC Therapeutics entered into a strategic financing collaboration with funds managed by Blackstone. Funds managed by Blackstone Life Sciences and Blackstone Credit will provide PTC with an initial $500 million commitment, including $350 million in low-cost, low-dilution capital at close.

Blackstone, GSO Lead $2B Financial Package for Alnylam Pharmaceuticals

Blackstone Life Sciences and GSO Capital Partners led a $2 billion financial collaboration in support of Alnylam Pharmaceuticals. The deal includes an up to $750 million first lien senior secured term loan led by GSO.